GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Jenscare Scientific Co Ltd (HKSE:09877) » Definitions » Other Net Income (Loss)

Jenscare Scientific Co (HKSE:09877) Other Net Income (Loss) : HK$0.00 Mil (TTM As of Dec. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Jenscare Scientific Co Other Net Income (Loss)?

Jenscare Scientific Co's Other Net Income (Loss) for the six months ended in Dec. 2024 was HK$0.00 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Dec. 2024 was HK$0.00 Mil.

Jenscare Scientific Co's quarterly Other Net Income (Loss) increased from Dec. 2023 (HK$0.00 Mil) to Jun. 2024 (HK$0.00 Mil) but then declined from Jun. 2024 (HK$0.00 Mil) to Dec. 2024 (HK$0.00 Mil).

Jenscare Scientific Co Other Net Income (Loss) Historical Data

The historical data trend for Jenscare Scientific Co's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jenscare Scientific Co Other Net Income (Loss) Chart

Jenscare Scientific Co Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
Other Net Income (Loss)
- - - - -

Jenscare Scientific Co Semi-Annual Data
Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Other Net Income (Loss) Get a 7-Day Free Trial Premium Member Only - - - - -

Jenscare Scientific Co Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Jenscare Scientific Co Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of Jenscare Scientific Co's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Jenscare Scientific Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Jenscare Scientific Co Ltd (HKSE:09877) » Definitions » Other Net Income (Loss)
Comparable Companies
HKSE:06669 HKSE:02235 HKSE:09996 HKSE:01763 HKSE:01696 HKSE:02160 HKSE:06922 HKSE:02500 HKSE:06609 HKSE:02216 ABT BSX SYK MDT XTER:SHL EW SZSE:300760 DXCM STE PODD
Traded in Other Exchanges
N/A
Address
No. 777 Binhai 4th Road, Block 5, B Area, Hangzhou Bay New Area, Zhejiang Province, Ningbo, CHN
Website
https://www.jenscare.com
Jenscare Scientific Co Ltd is engaged in the manufacturing and research and development of medical devices. The company develops interventional products for the treatment of structural heart disease. The company's core products include LuX-Valve and Ken-Valve. LuX-Valve is a transcatheter tricuspid valve replacement system designed for patients with severe tricuspid regurgitation and high surgical risk. Ken-Valve is designed for the treatment of severe aortic regurgitation or combined with aortic stenosis. The company also develops product candidates for the treatment of mitral valve diseases and medical devices for the treatment of heart failure.
Executives
Lv Shiwen 2501 Other
Li Hui 2501 Other
Shanghai Shidi Industrial Development Co., Ltd. 2501 Other
Ningbo Linfeng Biotechnology Co., Ltd. 2101 Beneficial owner
Onez International Limited 2101 Beneficial owner
Pan Fei 2201 Interest of corporation controlled by you
Trident Trust Company (hk) Limited 2301 Trustee
Trinity Elite I International Limited 2201 Interest of corporation controlled by you
Ningbo Dixiang Venture Capital Co., Ltd. 2201 Interest of corporation controlled by you
Shanghai Jiachen Investment Co.,ltd 2201 Interest of corporation controlled by you
Ningbo Sangdi Investment Management L.p. (limited Partnership) 2101 Beneficial owner
Hainan Yize Medical Technology Co., Limited 2201 Interest of corporation controlled by you
Hainan Maidi Enterprise Management L.p. (limited Partnership) 2101 Beneficial owner
Hainan Hualing Investment L.p. (limited Partnership) 2101 Beneficial owner
Hangzhou Chende Investment Partnership (limited Partnership) 2101 Beneficial owner

Jenscare Scientific Co Headlines

No Headlines